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ABSTRACT. The potency of oxytocin (OT) in evoking ACTH 
secretion by isolated, superfused rat adenohypophyseal cortico- 
trophs and its enhancement by CRF and arginine vasopressin 
(AVP) were analyzed. Each secretagogue effectively released 
ACTH from adenohypophyseal cells when added separately in 
pulsatile fashion in physiological concentrations based on hy- 
pophyseal portal blood (OT, 10 nM; AVP, 0.5 nM; CRF, 0.1 nM). 
OT released ACTH at concentrations as low as 1 nM. Moreover, 
a dose-response relationship up to 10 pM was revealed. Combi- 
nations of a constant amount of CRF (0.1 nM) with increasing 
concentrations of OT exerted a synergistic effect on ACTH 
release. In contrast, OT given in various concentrations in 
combination with AVP (0.5 nM) produced an additive effect on 
ACTH release. 
To study the mechanism of action of OT on ACTH secretion, 
cytosolic free calcium levels in single pituitary cells exposed to 
OT or AVP were measured using the calcium-sensitive fluores- 
cent indicator Fura-2. Corticotrophs among mixed adenohypo- 
physeal cell types in the primary cultures were identified by 
~mmunocytoch~mistry. M&e th& 500 cells were individually 
stimulated with OT or AVP. Basal cvtosolic free calcium levels 
ranged between SO-130 nM free calci&. The addition of 100 nM 
OT or 1 PM AVP increased the cytoeolic free calcium concentra- 
tion within 3 set to values ranging from 500-600 nM. An increase 
in intracellular calcium ranging from 200-500 nM due to OT 
could still be observed after extracellular calcium depletion. 
Taken together, our data demonstrate that physiological con- 
centrations of OT stimulate ACTH secretion, independent of 
the other ACTH secretagogues, by mobilizing calcium mainly 
from intracellular stores. (Endocrin&gy 130: 2163-2191,1992) 
S ECRETION of ACTH by the adenohypophysis is controlled by hypothalamic releasing hormones such 
as CRF and arginine vasopressin (AVP) (l-3). Yet, ac- 
cumulating evidence supports the notion that oxytocin 
(OT), in addition to its well-established role in parturi- 
tion and lactation, also participates in regulation of 
stress-induced ACTH secretion through the hypothal- 
amo-hypophyseal axis (4, 5). Several findings indicate 
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the existence of separate receptors for OT and vasopres- 
sin in the rat adenohypophysis (6, 7), reinforcing the 
notion that OT may function as a hypophysiotropic 
hormone. In addition, CRF-, AVP- and OT-containing 
neurons in the hypothalamic paraventricular and su- 
praoptic nuclei project to the median eminence and re- 
lease these peptides into hypophyseal portal blood (8- 
10). Here, the concentration of these peptides are several 
times greater compared to peripheral blood (11-15). 
Thus, OT as a part of this hypophysiotropic cocktail in 
the adenohypophyseal circulation could contribute to 
physiological regulation of ACTH secretion by the hy- 
pothalamus. 
To date, studies examining the effects of OT on ACTH 
release have not revealed evidence that OT alone, in 
physiological concentrations (10 nM), induces ACTH 
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ABSTRACT. The potency of oxytocin (OT) in evoking ACTH 
secretion by isolated, superfused rat adenohypophyseal cortico-
trophs and its enhancement by CRF and arginine vasopressin 
(A VP) were analyzed. Each secretagogue effectively released 
ACTH from adenohypophyseal cells when added separately in 
pulsatile fashion in physiological concentrations based on hy-
pophyseal portal blood (OT, 10 nM; AVP, 0.5 nM; CRF, 0.1 nM). 
OT released ACTH at concentrations as low as 1 nM. Moreover, 
a dose-response relationship up to 10 I'M was revealed. Combi-
nations oe a constant amount of CRF (0.1 nM) with increasing 
concentrations of OT exerted a synergistic effect on ACTH 
release. In contrast, OT given in various concentrations in 
combination with A VP (0.5 nM) produced an additive effect on 
ACTH release. 
To study the mechanism of action of OT on ACTH secretion, 
SECRETION of ACTH by the adenohypophysis is controlled by hypothalamic releasing hormones such 
as CRF and arginine vasopressin (AVP) (1-3). Yet, ac-
cumulating evidence supports the notion that oxytocin 
(OT), in addition to its well-established role in parturi-
tion and lactation, also participates in regulation of 
stress-induced ACTH secretion through the hypothal-
amo-hypophyseal axis (4, 5). Several findings indicate 
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cytosolic free calcium levels in single pituitary cells exposed to 
OT or A VP were measured using the calcium-sensitive fluores-
cent indicator Fura-2. Corticotrophs among mixed adenohypo-
physeal cell types in the primary cultures were identified by 
immunocytochemistry. More than 500 cells were individually 
stimulated with OT or AVP. Basal cytosolic free calcium levels 
ranged between 80-130 nM free calcium. The addition of 100 nM 
OT or II'M A VP increased the cytosolic free calcium concentra-
tion within 3 sec to values ranging from 500-800 nM. An increase 
in intracellular calcium ranging from 200-500 nM due to OT 
could still be observed after extracellular calcium depletion. 
Taken together, our data demonstrate that physiological con-
centrations of OT stimulate ACTH secretion, independent of 
the other ACTH secretagogues, by mobilizing calcium mainly 
from intracellular stores. (Endocrinology 130: 2183-2191, 1992) 
the existence of separate receptors for OT and vasopres-
sin in the rat adenohypophysis (6, 7), reinforcing the 
notion that OT may function as a hypophysiotropic 
hormone. In addition, CRF-, AVP- and OT-containing 
neurons in the hypothalamic paraventricular and su-
praoptic nuclei project to the median eminence and re-
lease these peptides into hypophyseal portal blood (8-
10). Here, the concentration ofthese peptides are several 
times greater compared to peripheral blood (11-15). 
Thus, OT as apart of this hypophysiotropic cocktail in 
the adenohypophyseal circulation could contribute to 
physiological regulation of ACTH secretion by the hy-
pothalamus. 
To date, studies examining the effects of OT on ACTH 
release have not revealed evidence that OT alone, in 
physiological concentrations (10 nM), induces ACTH 
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release (16, 17). Available data demonstrate that AVP, 
in vitro (18, 19) and in uivo (20), and OT (16) augment 
the ACTH release in response to CRF; but no effects of 
OT on the ACTH release in response to AVP were 
reported (21, 22). Recently, a kinetic analysis revealed 
synergistic effects of AVP and CRF on ACTH release 
(23). Therefore, the present study was designed to ex- 
amine the ACTH release responses from isolated, super- 
fused rat adenohypophyseal cells to pulsatile additions 
of physiological concentrations of OT in the presence or 
absence of CRF or AVP to determine whether these 
peptides enhance ACTH release. 
Furthermore, mechanism(s) which mediate secreta- 
gogue actions in rat adenohypophyseal corticotrophs 
leading to the release of ACTH utilize different intracel- 
lular signal transduction pathways depending on the 
secretagogue involved. Increases in intracellular calcium 
have been associated with the action of AVP (24-26). 
But, the precise mechanism of OT action on ACTH 
secretion has not been elucidated. Therefore, the role of 
calcium ions in the mechanism of OT action was studied 
by measuring cytosolic free calcium levels after a stimu- 
lus of OT or AVP in single, immunocytochemically iden- 
tified corticotrophs. We provide direct evidence, implying 
that OT acts by mobilizing intracellular stored calcium. 
Materials and Methods 
Animals 
Randomly cycling female rata (Wistar, 250-350 g body 
weight), obtained from Charles River Wiga GmbH, Sulzfeld, 
Germany, were maintained at 21-23 C with 12 h light, 12 h 
dark cycle (light on between 0700 h and 1900 h, local time) 
with free access to pelleted food and tap water. For each 
experiment ten animals, usually taken from separate cages in 
order to avoid stress-induced activation of the hypothalamo- 
hypophyseal system, were killed by decapitation (between 0800 
h and 0900 h). The adenohypophyses were quickly removed 
and further processed as described below. 
Chemicals 
Chemicals and reagents were obtained from the following 
sources: OT, Boehringer Mannheim (Mannheim, Germany); 
AVP, Bachem (Budendorf, Switzerland); trypsin (code TRL), 
Worthington Biochemical Corp (Freehold, NJ); medium [Dul- 
becco’s minimal essential medium (MEM)] for cell culture, 
Biochrom KG (Berlin, Germany); Dulbecco’s MEM for perfu- 
sion experiments, Flow Laboratories (Irvine, Scotland); fetal 
calf serum (FCS), Gibco (Berlin, Germany); BSA (tissue culture 
grade), Miles Laboratories (Elkhart, IN); Fura- and Fura-2/ 
AM (pentaacetoxymethylester), Calbiochem (La Jolla, CA); 
EGTA, Fluka (Neu-Ulm, Germany). All other chemicals, in- 
cluding rat CRF-41, human ACTHles9, DNAse I, antibiotic- 
antimycotic solution (specified below), HEPES, trypsin inhib- 
itor (from soybean), and aprotinin were purchased from Sigma 
(Deisenhofen, Germany). 
Isolation of aderwhypophyseal cells 
Anterior pituitary cells were isolated as described previously 
(27-29). Briefly, the excised adenohypophyses were placed in 
medium A (Dulbecco’s MEM, buffered with 22 mM HEPES at 
pH 7.4, containing 0.25% BSA and antibiotic-antimycotic sub- 
stances: Penicillin G, 100 U/ml; Streptomycin, 100 pg/ml; 
Amphotericin B, 0.25 rg/ml) and minced to approximately 0.5 
mm diameter segments. The tissue fragments were then enzy- 
matically dissociated by incubation in the above medium con- 
taining DNAse I (5 pg/ml) and trypsin (0.25%) for 20 min at 
37 C in a shaking water bath. The cells were further dispersed 
by mechanical trituration for 10 min in the trypsin solution 
and the cell suspensions centrifuged for 8 min at 200 x g. The 
supernatant was discarded, and the pellet was resuspended in 
10 ml of the above medium containing trypsin-inhibitor (0.5 
mg/ml) and aprotinin (0.25 trypsin inhibitor units/ml) and 
centrifuged as above, and the final pellet was resuspended in 
medium A. 
Sy>erfusion and stimzdution of cells 
Aliquots of cell suspensions containing approximately 3.5 X 
lo6 cells were mixed with 1 ml preswollen Sephadex G-10 
(Pharmacia; Uppsala, Sweden). Equal amounts of cell suspen- 
sions were then transferred onto perifusion columns (chamber 
volume was adjusted to 0.4 ml) made from disposable 2 ml 
syringes, which were kept in a thermostated incubator at 37 C. 
Perifusion with medium A was carried out according to previ- 
ously described methods (29, 30) using a multichannel peri- 
staltic pump (Ismatec IPNd; Zurich, Switzerland) at a flow 
rate of 0.25 ml/min. After an equilibration period of 2 h, which 
is required for basal hormone output to decrease to a low and 
constant level (29, 30), two priming secretagogue pulses, con- 
taining 0.05 nM CRF plus 10 nM OT, were applied to the 
columns for 5 min every 30 min to synchronize ACTH release 
from the cells (31). Then secretagogues were applied every 30 
min in a balanced random blocks design to four parallel col- 
umns. During the experimental period, 2 min fractions of the 
column effluents were collected using a microfraction collector 
(model 203; Gilson Medical Electronics, Villiers le Bel, France); 
samples were immediately frozen and stored at -20 C for 
subsequent RIA. Fifty microliter aliquots of the effluent were 
assayed for immunoreactive ACTH by RIA with a double 
antibody precipitation technique (16) using antiserum no. 6 
(courtesy of G. B. Makara and K. Kovacs, Budapest, Hungary). 
Purified human ACTH,-39 was used as the assay standard. 
Data analysis 
During a 5 min exposure to secretagogues, the concentrations 
of ACTH in the column effluent increased for 10 min, that is 
in five consecutive 2 min fractions. Net ACTH release for each 
stimulus was obtained by subtracting the basal value measured 
immediately before the application of a stimulus. Data am 
expressed as the mean + SEM. Statistical evaluation was per- 
formed by two-way nonparametric analysis of variance, fol- 
lowed by Student’s two-tailed unpaired t test. 
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gogue actions in rat adenohypophyseal corticotrophs 
leading to the release of ACTH utilize different intracel-
lular signal transduction pathways depending on the 
secretagogue involved. Increases in intracellular calcium 
have been associated with the action of AVP (24-26). 
But, the precise mechanism of OT action on ACTH 
secretion has not been elucidated. Therefore, the role of 
calcium ions in the mechanism of OT action was studied 
by measuring cytosolic free calcium levels after a stimu-
lus of OT or AVP in single, immunocytochemically iden-
tified corticotrophs. We provide direct evidence, implying 
that OT acts by mobilizing intracellular stored calcium. 
Materials and Methods 
Animals 
Randomly cycling female rats (Wistar, 250-350 g body 
weight), obtained from Charles River Wiga GmbH, Sulzfeld, 
Germany, were maintained at 21-23 C with 12 h light, 12 h 
dark cycle (light on between 0700 hand 1900 h, local time) 
with free access to pelleted food and tap water. For each 
experiment ten animals, usually taken from separate cages in 
order to avoid stress-induced activation of the hypothalamo-
hypophyseal system, were killed by decapitation (between 0800 
hand 0900 h). The adenohypophyses were quickly removed 
and further processed as described below. 
Chemicals 
Chemicals and reagents were obtained from the following 
sources: OT, Boehringer Mannheim (Mannheim, Germany); 
AVP, Bachem (Budendorf, Switzerland); trypsin (code TRL), 
Worthington Biochemical Corp (Freehold, NJ); medium [Dul-
becco's minimal essential medium (MEM) 1 for cell culture, 
Biochrom KG (Berlin, Germany); Dulbecco's MEM for perfu-
sion experiments, Flow Laboratories (Irvine, Scotland); fetal 
calf serum (FCS), Gibco (Berlin, Germany); BSA (tissue culture 
grade), Miles Laboratories (Elkhart, IN); Fura-2 and Fura-2/ 
AM (pentaacetoxymethylester), Calbiochem (La Jolla, CA); 
EGTA, Fluka (Neu-Ulm, Germany). All other chemicals, in-
cluding rat CRF-41, human ACTHI- 39, DNAse I, antibiotic-
antimycotic solution (specified below), HEPES, trypsin inhib-
itor (from soybean), and aprotinin were purchased from Sigma 
(Deisenhofen, Germany). 
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 dia eter seg ents. The tissue frag ents ere then enzy-
atically dissociated by incubation in the above ediu  con-
taining Ase I (5 ~g/ml) and trypsin (0.25 ) for 20 in at 
37 C in a shaking water bath. The cells were further dispersed 
by echanical trituration for 10 in in the trypsin solution 
and the cell suspensions centrifuged for 8 min at 200 X g. The 
supernatant was discarded, and the pellet was resuspended in 
10 l of the above ediu  containing trypsin-inhibitor (0.5 
mg/mI) and aprotinin (0.25 trypsin inhibitor units/ml) and 
centrifuged as above, and the final pellet was resuspended in 
mediumA. 
Superfusion and stimulation 01 cells 
Aliquots of cell suspensions containing approximately 3.5 x 
106 cells were mixed with 1 ml preswollen Sephadex G·10 
(Pharmacia; Uppsala, Sweden). Equal amounts of cell suspen-
sions were then transferred onto perifusion columns (chamber 
volume was adjusted to 0.4 ml) made from disposable 2 ml 
syringes, which were kept in a thermostated incubator at 37 C. 
Perifusion with medium A was carried out according to previ-
ously described methods (29, 30) using a multichannel peri-
staltic pump (Ismatec IPN-8; Zürich, Switzerland) at a flow 
rate of 0.25 ml/min. After an equilibration period of 2 h, which 
is required for basal hormone output to decrease to a low and 
constant level (29, 30), two priming secretagogue pulses, con-
taining 0.05 nM CRF plus 10 nM OT, were applied to the 
columns for 5 min every 30 min to synchronize ACTH release 
from the cells (31). Then secretagogues were applied every 30 
min in a balanced random blocks design to four parallel col-
umns. During the experimental period, 2 min fractions of the 
column effluents were collected using a microfraction collector 
(model 203; Gilson Medical Electronics, Villiers le Bel, France); 
sampies were immediately frozen and stored at -20 C for 
subsequent RIA. Fifty microliter aliquots of the effluent were 
assayed for immunoreactive ACTH by RIA with a double 
antibody precipitation technique (16) using antiserum no. 6 
(courtesy of G. B. Makara and K. Kovacs, Budapest, Hungary). 
Purified human ACTHI_39 was used as the assay standard. 
Data analysis 
During a 5 min exposure to secretagogues, the concentrations 
of ACTH in the column effluent increased for 10 min, that is 
in five consecutive 2 min fractions. Net ACTH release for each 
stimulus was obtained by subtracting the basal value measured 
immediately before the application of a stimulus. Data are 
expressed as the mean ± SEM. Statistical evaluation was per-
formed by two-way nonparametric analysis of variance, fol· 
lowed by Student's two-tailed unpaired t test. 
MECHANISMS OF OXYTOCIN-EVOKED ACTH RELEASE 2135 
Primary cultures of pituitary cells 
Adenohypophyses were removed under sterile conditions, 
and the cells were isolated as described above using medium B 
(Dulbecco’s MEM for culture buffered with 44 mM sodium 
hydrogen carbonate at pH 7.2, containing 37 mM glucose and 
antibiotic-antimycotic substances: Penicillin, 500 U/ml; Strep- 
tomycin, 500 Fg/ml) containing 10% BSA. Aliquots of cell 
suspensions were plated in poly-L-lysine-coated plastic petri- 
dishes with medium B containing 20 mM cytosine$-D-arabino- 
furanoside and 5% FCS and incubated in a humidified atmos- 
phere (5% COJ95% air) at 37 C for 3 days. The medium was 
changed after 24 h and subsequently every 2 days. 
Measurement of intracelluhzr free calcium of single cells 
Cultured pituitary cells were washed with FCS-free medium 
to remove serum before loading the cells with Fura-Z/AM, 
which was first dissolved in pure dimethyl sulfoxide and then 
diluted with FCS-free medium to 1.5 PM Fura-Z/AM and 0.1% 
dimethyl sulfoxide. Dye loading was carried out for 15-30 min 
at 37 C. Subsequently the cells were washed with measuring 
buffer [in millimolar concentration: 140 NaCI; 4.7 KC1; 1.2 
KH,PO,; 1.2 MgSO,; 1 CaCl*; 0.5 ascorbic acid; 11 glucose; 15 
piperazine-NJV’-bis(2-ethanesulfonic acid), pH 7.21 and used 
for Ca*+ measurement studies up to 4 h after dye loading. 
Fluorescence measurements of intracellular calcium were per- 
formed with the Zeiss Microscope Photometer System (FFP). 
The system is based on an inverted microscope (Axiovert 35), 
equipped for epifluorescence. A Xenon lamp (Wotan, XBO 75 
W/2) with quartz collector is used for excitation. Interference 
filters of 340/10 run and 380/10 nm are alternatively mounted 
in the filter wheel. In this configuration, the two excitation 
wavelengths can be changed with a frequency of 200 Hz, re- 
sulting in a maximum time resolution of 5 msec. The light is 
deflected by a dichroic mirror (Zeiss FT 425) through the 
microscope objective (Zeiss LD Achroplan 40x Ph2) to the cells 
to be analyzed. Fluorescence light from an area adjusted to the 
cell size, approximately 10 pm in diameter, is collected. 
With fluorescence values corrected for background and dark 
current, ratio calculations of the 340 nm recordings divided by 
the 380 nm recordings were carried out according to Grynkiew- 
icz et al. (32). 
Test substances were added with a motor-driven syringe 
(Hamilton microlab P system, Bonaduz, Switzerland; speed 
setting 9). All test substances were diluted with the measuring 
buffer and added in a total volume of 25 ~1. This method 
permitted rapid and highly reproducible changes of the medium 
surrounding a selected cell. Five to ten cells from one culture 
dish were randomly selected and measured while stimuli were 
applied. The responding cells were video-printed. The cells 
were then washed twice with measuring buffer and, after a lo- 
15 min intermission, the same or a different cell was subjected 
to the next secretagogue treatment. 
Immurw@ochemihy of analyzed cells 
After calcium measurements corticotrophs were identified 
among the mixed cell population in the cultures by immuno- 
cytochemistry. Cultures were fixed in cold paraformaldehyde 
(4% in 10 mM PBS, pH 7.2) for 30 min before anti-ACTH 
antiserum (courtesy of G. B. Makara and K. Kovacs; Budapest, 
Hungary) was applied in a dilution of 1:2000 in phosphate (10 
mM)-buffered saline containing 0.5% BSA. Incubation was 
carried out overnight at 4 C. Antigen-antibody complexes were 
visualized by the double antibody avidin-biotin-peroxidase 
complex (ABC) technique (Avidin Biotin Complex Vectastain- 
kit, Vector Laboratories; Burlingham, CA) according to a pre- 
viously published procedure (33). Staining was developed with 
3,3’-diaminobenzidine-tetrahydrochloride (Aldrich, Milwau- 
kee, WI) in the presence of 0.01% HzOz, dissolved in Tris-HCl 
buffer (50 mM, pH 7.6). Controls consisted of 1) omitting the 
first antiserum and incubations with respective buffers (anti- 
body specificity) and 2) incubation with normal rabbit serum 
(1:2000) instead of the specific antiserum (method specificity). 
The coordinates of the cells stained on the plate allowed iden- 
tification of the cells previously analyzed for intracellular cal- 
cium concentrations. 
Results 
ACTH response to OT by perifused adenohypophyseal 
cells 
Dispersed rat adenohypophyseal cells were challenged 
with secretagogue treatments in a column perifusion 
system. Fig. 1 shows the ACTH responses to five subse- 
quent pulses of 10 nM OT. The cells were repeatedly 
exposed to OT stimulation every 30 min for a 5 min 
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FIG. 1. ACTH release by perifueed adenobypophyseal cells in response 
to consecutive stimuli of 10 nM OT. Data are expressed as percent of 
total ACTH released from the respective columns during 190 min of 
the experimental period and detected in the 2 min fractions. Horizontal 
bars indicate application of OT for 5 min; points represent means of 
three experiments, uertical bars show the SEM. The basal rate of ACTH 
secretion in this experiment was 2 f  0.4 fmol/2 min fraction of one 
column. 
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dimethyl sulfoxide. Dye loading was carried out for 15-30 min 
at 37 C. Subsequently the cells were washed with measuring 
buffer [in millimolar concentration: 140 NaCl; 4.7 KC1; 1.2 
KH2P04; 1.2 MgS04: 1 CaCI2; 0.5 ascorbic acid; 11 glucose; 15 
piperazine-N,N'-bis(2-ethanesulfonic acid), pH 7.2] and used 
for Ca2+ measurement studies up to 4 h alter dye loading. 
Fluorescence measurements of intracellular calcium were per-
formed with the Zeiss Microscope Photometer System (FFP). 
The system is based on an inverted microscope (Axiovert 35), 
equipped for epifluorescence. A Xenon lamp (Wotan, XBO 75 
W /2) with quartz collector is used for excitation. Interference 
filters of 340/10 nm and 380/10 nm are alternatively mounted 
in the filter wheel. In this configuration, the two excitation 
wavelengths can be changed with a frequency of 200 Hz, re-
sulting in a maximum time resolution of 5 msec. The light is 
deflected by a dichroic mirror (Zeiss FT 425) through the 
microscope objective (Zeiss LD Achroplan 40x Ph2) to the cells 
to be analyzed. Fluorescence light from an area adjusted to the 
cell size, approximately 10 /.'m in diameter, is collected. 
With fluorescence values corrected for background and dark 
current, ratio calculations of the 340 nm recordings divided by 
the 380 nm recordings were carried out according to Grynkiew-
icz et al. (32). 
Test substances were added with a motor-driven syringe 
(Hamilton microlab P system, Bonaduz, Switzerland: speed 
setting 9). All test substances were diluted with the measuring 
buffer and added in a total volume of 25 /.'1. This method 
permitted rapid and highly reproducible changes of the medium 
surrounding a selected cello Five to ten cells from one culture 
dish were randomly selected and measured while stimuli were 
applied. The responding cells were video-printed. The cells 
were then washed twice with measuring buffer and, alter a 10-
15 min intermission, the same or a different cell was subjected 
to the next secretagogue treatment. 
lmmunocytochemistry 01 analyzed cells 
After calcium measurements corticotrophs were identified 
among the mixed cell population in the cultures by immuno-
cytochemistry. Cultures were fixed in cold paraformaldehyde 
(4% in 10 mM PBS, pH 7.2) for 30 min before anti-ACTH 
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The coordinates of the cells stained on the plate allo ed iden-
tification of the cella previously analyzed for intracellular cal-
ciu  concentrations. 
esults 
ACTH response to T by perifused adenohypophyseal 
cells 
Dispersed rat adenohypophyseal cells were challenged 
with secretagogue treatments in a column perifusion 
system. Fig. 1 shows the ACTH responses to five subse-
quent pulses of 10 nM OT. The cells were repeatedly 
exposed to OT stimulation every 30 min for a 5 min 
5 
4 
2 
O+-~--~--r-~--~~--~--r-~~
o 20 40 60 80 100 120 140 160 180 200 
mln 
FIG. 1. ACTH release by perifused adenohypophyseal cells in response 
to consecutive stimuli of 10 nM OT. Data are expressed as percent of 
total ACTH released €rom the respective columns during 190 min of 
the experimental period and detected in the 2 min fractions. Horizontal 
bars indicate application of OT for 5 min; points represent means of 
three experiments; vertical bars show the SEM. The basal rate of ACTH 
secretion in this experiment was 2 ± 0.4 fmol/2 min fraction of one 
column. 
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period as indicated by the horizontal bars. The rate of 
basal ACTH release was l-1.5% of the total release, 
which corresponded to 2 f 0.4 fmol/2 min fraction of 
one column, and remained nearly constant during the 
experimental period. We observed an almost constant 
amount of ACTH release during all subsequent pulses of 
OT. The increase in ACTH release due to OT returned 
to baseline values within 10 min after the stimulus was 
removed. 
Using a similar protocol, the cells were exposed for 5 
min to increasing concentrations of OT (0.1 nM up to f0 
PM). Each concentration was infused a total of three 
times in random order at 30 min intervals into one of 
three identical columns. OT-evoked release of ACTH 
was evident at 0.1 nM and ACTH release increased dose 
dependently up to 20-fold at 10 I.IM OT, the highest 
concentration applied (Fig. 2). 
ACTH release by various secretagogues in physiological 
concentrations 
The release of ACTH elicited by physiological doses, 
based on hypophyseal portal blood concentrations, of OT 
(10 nM) (ll), AVP (0.5 nM) (14), or CRF (0.1 nM) (13) 
is shown in Fig. 3. The results demonstrate that the 
potency of 10 nM OT to induce ACTH secretion is lower 
compared to that of 0.5 nM AVP or 0.1 nM CRF. To our 
knowledge, in this and the previous experiments shown 
above, for the first time, a significant effect of OT in 
physiological concentration on ACTH release is demon- 
strated. 
F loo- 
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OT concentration (M) 
FIG. 2. Release of ACTH by perifused anterior pituitary cells in re- 
sponse to OT. Cells were exposed to different concentrations of OT for 
5 min in a randomized, complete block design. Data are means of the 
net ACTH release; bars indicate the SEM (n = 3). The release caused 
by 0.1 nM OT was significant at a level of P < 0.2 us. basal release, and 
the release elicited by higher OT concentrations was significant at a 
level of P < 0.05. 
OT 
10 nM 0.5 nM 
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FIG. 3. ACTH release by perifused anterior pituitary cells after treat- 
ment with various secretagogues. ACTH secretion evoked by OT (10 
nM), AVP (0.5 nM), or CFW (0.1 nM) is expressed as mean of the net 
ACTH released during three secretory responses. Each bar represents 
the mean f  SEM. For all three substances evoked us. basal release was 
significant (P C 0.05). 
Release of ACTH by OT in the presence of CRF or A VP 
We also examined the ACTH release by OT in differ- 
ent concentrations in the presence of the two hypotha- 
lamic releasing hormones, CRF or AVP. Available evi- 
dence implies that both peptides are involved in the 
physiological regulation of ACTH secretion (2). To de- 
termine whether OT is a functional component of the 
releasing hormone cocktail regulating adenohypophyseal 
responses, the effects of these stimuli on ACTH release 
were examined. We tested the ACTH release response 
to CRF alone (0.1 nM) and to mixtures of CRF (0.1 nM) 
and OT in concentrations of 1 nM, 10 nM, 100 nM, 1 pM, 
and 10 pM (Fig. 4). 
The data reveal that the ACTH-releasing effect of 
CRF was augmented in the presence of OT, because 
ACTH release by all five peptide combinations (open 
columns) was more than the calculated sum of ACTH 
release elicited by CRF and OT applied separately 
(hatched columns). The 10 min net ACTH release in- 
duced by the CRF/OT mixtures with OT concentrations 
of 100 nM, 1 PM, and 10 PM were 1.2, 1.4, and 1.7 times 
greater, respectively, than the sums of the responses to 
CRF and OT alone. The synergism of CRF and OT on 
ACTH release was significant over this range of concen- 
trations. 
In contrast, when AVP in a fixed concentration of 0.5 
nM was perifused simultaneously with OT in different 
concentrations in the same experimental design as above, 
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dependently up to 20-fold at 10 ILM OT, the highest 
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ACTH release by various secretagogues in physiological 
concentrations 
The release of ACTH elicited by physiological doses, 
based on hypophyseal portal blood concentrations, of OT 
(10 nM) (11), AVP (0.5 nM) (14), or CRF (0.1 nM) (13) 
is shown in Fig. 3. The results demonstrate that the 
potency of 10 nM OT to induce ACTH secretion is lower 
compared to that of 0.5 nM AVP or 0.1 nM CRF. To our 
knowledge, in this and the previous experiments shown 
above, for the first time, a significant effect of OT in 
physiological concentration on ACTH release is demon-
strated. 
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FIG. 2. Release of ACTH by perifused anterior pituitary cells in re-
sponse to OT. Cella were exposed to different concentrations of OT for 
5 min in a randomized, complete block design. Data are means of the 
net ACTH release; bars indicate the SEM (n = 3). The release caused 
by 0.1 nM OT was significant at a level of P < 0.2 vs. basal release, and 
the release elicited by higher OT concentrations was significant at a 
level of P < 0.05. 
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FIG. 3. ACTH release by perifused anterior pituitary ceUs after treat-
ment with various secretagogues. ACTH secretion evoked by OT (10 
nM), A VP (0.5 nM), or CRF (0.1 nM) is expressed as mean of the net 
ACTH released during three secretory responses. Each bar represents 
the mean ± SEM. For all three substances evoked vs. basal release was 
significant (P < 0.05). 
Release o{ ACTH by OT in the presence o{ CRF or A VP 
We also examined the ACTH release by OT in differ-
ent concentrations in the presence of the two hypotha-
lamic releasing hormones, CRF or AVP. Available evi-
dence implies that both peptides are involved in the 
physiological regulation of ACTH secretion (2). To de-
termine whether OT is a functional component of the 
releasing hormone cocktail regulating adenohypophyseal 
responses, the effects of these stimuli on ACTH release 
were examined. We tested the ACTH release response 
to CRF alone (0.1 nM) and to mixtures of CRF (0.1 nM) 
and OT in concentrations of 1 nM, 10 nM, 100 nM, 11LM, 
and 10 ILM (Fig. 4). 
The data reveal that the ACTH-releasing effect of 
CRF was augmented in the presence of OT, because 
ACTH release by all five peptide combinations (open 
columns) was more than the calculated sum of ACTH 
release elicited by CRF and OT applied separately 
(hatched columns). The 10 min net ACTH release in-
duced by the CRF lOT mixtures with OT concentrations 
of 100 nM, 11LM, and 10 ILM were 1.2, 1.4, and 1.7 times 
greater, respectively, than the sums of the responses to 
CRF and OT alone. The synergism of CRF and OT on 
ACTH release was significant over this range of concen-
trations. 
In contrast, when A VP in a fixed concentration of 0.5 
nM was perifused simultaneously with OT in different 
concentrations in the same experimental design as above, 
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FIG. 4. ACTH release by perifused anterior pituitary cells evoked by 
OT in the presence of CRF. CRF (0.1 n&i; cross-hatched column) or 
combinations of OT (1.0 nM to 10 PM; see abscissa) and CRF (0.1 nM) 
were applied to perifusion columns. Open columns indicate ACTH 
release obtained with OT-CRF combinations; hatched columns repre- 
sent ACTH released by 0.1 nM CRF plus the ACTH released by OT in 
the concentrations indicated (see also Fig. 2). Data are means of the 
net release of hormone from three experiments f  SEM. The synergistic 
effects of OT-CRF combinations was significant for CRF (0.1 nM) + 
OT [lo0 nhi; P < 0.2 (*)I, and for CRF (0.1 nhi) with 1 PM or 10 PM 
OT [P < 0.05 (*‘)I. Note the scale of this figure is different from Fig. 
2 and Fig. 5. 
the ACTH release differed only slightly from the calcu- 
lated sum of release when each peptide was added sepa- 
rately to the perifused cells (Fig. 5). The differences 
between calculated (hatched coZumn..s) and measured 
(open colunn.s) ACTH release evoked by the AVP/OT 
combinations are not significant for any concentration 
of OT. These data indicate that the effect of OT on AVP- 
induced ACTH release when perifused simultaneously is 
additive. This additive effect implies similar or even 
identical mechanisms of intracellular signal transduction 
processes involved in the ACTH-releasing action of these 
two hormones. 
Changes in intracellular free calcium concentration 
caused by OT and AVP 
Cultures from 10 different cell preparations provided 
the individual adenohypophyseal cells analyzed for cy- 
toplasmic free calcium. More than 500 cells were each 
stimulated with either AVP or OT in concentrations of 
1 PM and 100 nM, respectively. Calcium concentrations 
in each cell were recorded for periods of 90 or 120 sec. 
Basal resting intracellular calcium levels were stable and 
AVP AVP AVP AVP AVP AVP 
0; 0; 0; Of, 0; 
10” lo4 10-7 
5 *lo-l0 
10-s 10” 
FIG. 5. Release of ACTH by perifused anterior pituitary cells evoked 
by OT in the presence of AVP. The ACTH release evoked by AVP (0.5 
nM; cross-hutched column) and by combinations of AVP (0.5 nM) with 
varying concentrations of OT (open columns) is shown. Data are means 
of three different experiments f  SEM. The differences in net ACTH 
release evoked by the ,AVP-OT-combinations (open columns), com- 
pared to the calculated sum of the AVP-value plus respective OT- 
values (hutched column-s), was not significant for any concentration of 
OT (P > 0.06). 
ranged from 80-130 nM for responsive pituitary cells (n 
= 191 individual cells out of 524 examined cells). Corti- 
cotrophs in the mixed population of anterior pituitary 
cells were later identified by immunocytochemistry. 
Addition of OT (100 nM) increased the cytosolic free 
calcium concentrations to values ranging from 500-800 
nM in 30 (of 32) identified corticotrophs. Increased in- 
tracellular calcium was evident within 3 set, then de- 
clined in lo-15 set toward a plateau slightly higher than 
the calcium concentration observed under resting con- 
ditions (Fig. 6A). It was possible to trigger a second and 
third (not shown) calcium transient from the same cor- 
ticotroph cell provided that subsequent challenges were 
at least 10 min apart (Fig. 6B). 
An equivalent increase in the calcium concentration 
was observed when corticotrophs, which were first stim- 
ulated with OT, were challenged subsequently with 1 PM 
AVP (6 of 6 cells; Fig. 7). OT- or AVP-induced intracel- 
lular calcium concentration response profiles were not 
substantially different with respect to onset (rapid in- 
crease within 3 set), height of peak, or rate of subsequent 
decrease to basal levels. 
To explore whether the OT-induced increase in intra- 
cellular calcium was due to an influx of calcium or to a 
redistribution of intracellular stored calcium, we carried 
out a set of experiments in 0.1 pM extracellular calcium, 
which corresponds to the basal value of intracellular 
calcium concentration as observed with Fura- measure- 
ments (see Figs. 6 and 7). The calcium concentration was 
buffered at 0.1 PM free calcium with EGTA, and this low 
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FlG. 4. ACTH release by perifused anterior pituitary cella evoked by 
OT in the presence of CRF. CRF (0.1 nM; cross-hatched column) or 
eombinations of OT (1.0 nM to 10 I'M; see abscissa) and CRF (0.1 nM) 
were applied to perifusion columns. Open columns indieate ACTH 
release obtained with OT-CRF eombinations; hatched columns repre-
sent ACTH released by 0.1 nM CRF plus the ACTH released by OT in 
the concentrations indicated (see also Fig. 2). Data are means of the 
net release of hormone from three experiments ± SEM. The synergistie 
effects of OT-CRF combinations was signifieant for CRF (0.1 nM) + 
OT [100 nM; P < 0.2 (*)], and for CRF (0.1 nM) with 1l'M or 10 I'M 
OT [P< 0.05 (")]. Note the seale of this figure is different from Fig. 
2 and Fig. 5. 
the ACTH release differed only slightly from the calcu-
lated sum of release when each peptide was added sepa-
rately to the perifused cells (Fig. 5). The differences 
between calculated (hatched columns) and measured 
(open columns) ACTH release evoked by the A VP lOT 
combinations are not significant for any concentration 
ofOT. These data indicate that the effect ofOT on AVP-
induced ACTH release when perifused simultaneously is 
additive. This additive effect implies similar or even 
identical mechanisms of intracellular signal transduction 
processes involved in the ACTH-releasing action ofthese 
two hormones. 
Changes in intracellular free calcium concentration 
caused by OT and A VP 
Cultures from 10 different cell preparations provided 
the individual adenohypophyseal cells analyzed for cy-
toplasmic free calcium. More than 500 cells were each 
stimulated with either A VP or OT in concentrations of 
1 ~M and 100 nM, respectively. Calcium concentrations 
in each cell were recorded for periods of 90 or 120 sec. 
Basal resting intracellular calcium levels were stable and 
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FlG. 5. Release of ACTH by perifused anterior pituitary cells evoked 
by OT in the presence of A VP. The ACTH release evoked by A VP (0.5 
nM; cross-hatched column) and by eombinations of AVP (0.5 nM) with 
varying concentrations of OT (open columns) is shown. Data are means 
of three different experiments ± SEM. The differences in net ACTH 
release evoked by the AVP-OT-eombinations (open columns), com· 
pared to the calculated sum of the AVP-value plus respective OT· 
values (hatched columns), was not significant for any coneentration of 
OT (P > 0.06). 
ranged from 80-130 nM for responsive pituitary cells (n 
= 191 individual cells out of 524 examined cells). Corti-
cotrophs in the mixed population of anterior pituitary 
cells were later identified by immunocytochemistry. 
Addition of OT (100 nM) increased the cytosolic free 
calcium concentrations to values ranging from 500-800 
nM in 30 (of 32) identitied corticotrophs. Increased in-
tracellular calcium was evident within 3 sec, then de-
clined in 10-15 sec toward a plateau slightly higher than 
the calcium concentration observed underresting con-
ditions (Fig. 6A). It was possible to trigger a second and 
third (not shown) calcium transient from the same cor-
ticotroph cell provided that subsequent challenges were 
at least 10 min apart (Fig. 6B). 
An equivalent increase in the calcium concentration 
was observed when corticotrophs, which were first stim-
ulated with OT, were challenged subsequently with 1 ~M 
AVP (6 of 6 cells; Fig. 7). OT- or AVP-induced intracel-
lular calcium concentration response profiles were not 
substantially different with respect to onset (rapid in-
crease within 3 sec), height ofpeak, or rate of subsequent 
decrease to basal levels. 
To explore whether the OT-induced increase in intra-
cellular calcium was due to an influx of calcium or to a 
redistribution of intracellular stored calcium, we carried 
out a set of experiments in 0.1 pM extracellular calcium, 
which corresponds to the basal value of intracellular 
calcium concentration as observed with Fura-2 measure-
ments (see Figs. 6 and 7). The calcium concentration was 
buffered at 0.1 ~M free calcium with EGTA, and this low 
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FIG. 6. Rise of OT-induced intracellular 
calcium in a single, immunocytochemi- 
tally identified corticotroph. The corti- 
cotroph was subjected to two (A and B) 
consecutive stimuli of 166 nM OT, sep- 
arated by a 10 min intermission after 
washing. The intracellular free calcium 
level had returned to the prestimulation 
basal value before application of the sec- 
ond stimulus. Note the marked increase 
in free intracellular calcium immediately 
after OT application. Both calcium tran- 
sients (A and B) were similar with a 
slightly higher basal level of calcium be- 
fore the second stimulus. 
FIG. 7. Increase in intracellular calcium 
of an identified corticotroph cell in re- 
sponse to both OT or AVP. A, Intracel- 
lular calcium rapidly increases in a single 
immunccytochemically identified corti- 
cotroph by a challenge with OT (166 
nM). B, After a 10 min intermission and 
washing, the same cell was challenged 
with AVP (1 PM). Arrows indicate addi- 
tions of OT or AVP. The profiles shown 
are representative of six cells treated in 
the same manner. 
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calcium concentration was controlled with a calcium- 
selective electrode (34). After the 10 min intermission 
between different treatments, culture dishes were washed 
twice with the buffer containing 0.1 PM free calcium, and 
cells were then submitted to subsequent treatments. First 
we determined the effect of depolarizing concentrations 
of K+ (48 mM). None of five analyzed cells, which exhib- 
ited a calcium transient in measuring buffer containing 
1 mM calcium, responded in 0.1 pM extracellular calcium. 
However, four of these cells again showed a calcium 
transient when placed into measuring buffer containing 
1 mM calcium (see &teri& and Methods), indicating 
the viability and the control of voltage-dependent cal- 
cium channels of the tested cells. Basal intracellular 
calcium levels in identified corticotrophs were similar at 
0.1 pM extracellular calcium compared to 1 mM calcium. 
When OT (100 nM) was added to single cells in buffer 
containing 1 mM calcium (see Figs. 6, 7A, and 8A), a 
remarkable increase in intracellular calcium concentra- 
tion ranging from 500-800 nM was observed. At 0.1 PM 
extracellular calcium, 8 of 12 corticotrophs also re- 
sponded to OT. However, the rapidity of the increase in 
intracellular calcium was slower, and the decline period 
of calcium transients to basal values was longer (see Fig. 
8B). Usually, we found peak values of intracellular free 
calcium ranging from 200-500 nM. These data support 
W soo- 
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the notion that OT mobilizes a transient release of 
calcium mainly from an intracellular pool in single iden- 
tified corticotroph cells. 
Discussion 
The data presented here show that OT at physiological 
concentrations stimulates ACTH secretion by isolated, 
rat adenohypophyseal corticotrophs and interacts in dif- 
ferent ways with CRF or AVP in exerting their ACTH 
secretagoguic actions. OT markedly synergizes the 
ACTH secretagoguic activity of CRF and has an additive 
effect on AVP action. In addition, our results reveal a 
basic mechanism of OT action; specifically, it triggers an 
increase of intracellular calcium by mobilizing calcium 
from intracellular stores leading to ACTH secretion from 
pituitary corticotrophs. 
Secretion of ACTH occurs in a pulsatile manner and 
is closely correlated with pulsatile releases of hypotha- 
lamic factors into hypophyseal portal blood (3536). We 
mimicked this process in a continuous, in vitro column 
perifusion system (30), whereby the isolated adenohy- 
pophyseal cells were stimulated for short periods of time 
(5 min) at regular intervals with concentrations of secre- 
tagogues similar to those found in rat portal blood (11, 
13-15). Interestingly, with l-10 nM OT, i.e. in concen- 
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sponse to both OT or A VP. A, Intracel-
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calcium concentration was controlled with a calcium-
selective electrode (34). After the 10 min intermission 
between different treatments, culture dishes were washed 
twice with the buffer containing O.lp,M free calcium, and 
cells were then submitted to subsequent treatments. First 
we determined the effect of depolarizing concentrations 
of K+ (48 mM). None of five analyzed cells, which exhib-
ited a calcium transient in measuring buffer containing 
1 mM calcium, responded in O.lp,M extracellular calcium. 
However, four of these cells again showed a calcium 
transient when placed into measuring buffer containing 
1 mM calcium (see Materials and Methods), indicating 
the viability and the control of voltage-dependent cal-
cium channels of the tested cells. Basal intracellular 
calcium levels in identified corticotrophs were similar at 
O.lp,M extracellular calcium compared to 1 mM calcium. 
When OT (100 nM) was added to single cells in buffer 
containing 1 mM calcium (see Figs. 6, 7A, and 8A), a 
remarkable increase in intracellular calcium concentra-
tion ranging from 500-800 nM was observed. At O.lp,M 
extracellular calcium, 8 of 12 corticotrophs also re-
sponded to OT. However, the rapidity of the increase in 
intracellular calcium was slower, and the decline period 
of calcium transients to basal values was longer (see Fig. 
8B). Usually, we found peak values of intracellular free 
calcium ranging from 200-500 nM. These data support 
) 800 ) 
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(nM) 800 
400 
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. 
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0 
60 80 100 20 40 60 60 100 
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the notion that OT mobilizes a transient release of 
calcium mainly from an intracellular pool in single iden-
tified corticotroph cells. 
Discussion 
The data presented here show that OT at physiological 
concentrations stimulates ACTH secretion by isolated, 
rat adenohypophyseal corticotrophs and interacts in dif-
ferent ways with CRF or A VP in exerting their ACTH 
secretagoguic actions. OT markedly synergizes the 
ACTH secretagoguic activity of CRF and has an additive 
effect on A VP action. In addition, our results reveal a 
basic mechanism of OT action; specifically, it triggers an 
increase of intracellular calcium by mobilizing calcium 
from intracellular stores leading to ACTH secretion from 
pituitary corticotrophs. 
Secretion of ACTH occurs in a pulsatile manner and 
is closely correlated with pulsatile releases of hypotha-
lamic factors into hypophyseal portal blood (35, 36). We 
mimicked this process in a continuous, in vitra column 
perifusion system (30), whereby the isolated adenohy-
pophyseal cells were stimulated for short periods of time 
(5 min) at regular intervals with concentrations of secre-
tagogues similar to those found in rat portal blood (11, 
13-15). Interestingly, with 1-10 nM OT, i.e. in concen-
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FIG. 8. Corticotroph responses to OT in 
1 mM and 0.1 pM extracellular calcium. 
A, After the initial OT stimulus in the 
presence of 1 mM calcium, the cells were 
washed with buffer containing 0.1 pM 
free calcium. B. The resnonse to OT at 
0.1 pM calcium implies that intracellular 
stores are involved. The calcium re- 
sponse is representative of 8 of 12 cells 
subjected to the same protocol. C, Video 
print of the adenohypophyseal cell, 
which responded to OT as shown in 
panels A and B. D, Identification of the 
cell as a corticotroph by ACTH-immu- 
nocytochemistry. Arrowhead points to 
the measured and identified cortico- 
troph; arrows indicate neighboring 
ACTH negative cells; bar = 10 pM. 
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trations found in rat portal blood (11, 15), the release of 
ACTH was not saturated but increased in a dose-de- 
pendent manner up to 10 PM, the highest concentration 
tested. The threshold-stimulating concentration of OT 
was approximately 1 nM, which is close to estimates of 
the affinity [dissociation constant (Ka) = 1.5 nM] of 
specific receptors for OT measured in total adenohypo- 
physeal membranes (7). Both the presence of separate 
receptors for AVP (37, 38) and OT (7) and the ACTH 
secretion elicited by physiological OT concentrations 
suggest a specific role for OT in the regulation of ACTH 
secretion. In addition, various forms of stress are known 
to affect OT release in the rat (for review see Ref. 21). 
Several studies report 5 to lo-fold increases of OT in 
blood plasma during stress (4, 39, 40). A recent study 
(41) reported increased OT levels in cerebrospinal fluid, 
accompanied by increased plasma OT after different 
kinds of stress suggesting that cerebrospinal fluid hor- 
mone levels reflect to some degree the neurosecretory 
activity in the brain. Plotsky et al. (42) observed a 2-fold 
increase in portal blood OT concentration after hemor- 
rhage as a stressor, but did not report OT values exceed- 
ing 3.5 nM under their experimental conditions. To date, 
these data and our results suggest that ACTH secretion 
in the rat is physiologically regulated by l-10 nM OT, 
although higher concentrations of OT can elicit a pro- 
nounced ACTH release. ACTH secretion by high con- 
centrations of OT was also observed in earlier studies 
employing superfused hemipituitaries or cultured pitui- 
tary cells (17, 22, 25). 
The possibility of a role for OT release in the external 
zone of the median eminence (8, 9, 43, 44) into hypo- 
physeal portal blood in the regulation of ACTH secretion 
is intriguing. Available evidence suggests that OT serves 
as an ACTH-releasing factor in the AVP-deficient Brat- 
tleboro rat (45). Moreover, previously reported data also 
reveal that OT in certain kinds of stress is involved in 
the regulation of ACTH secretion, supporting the con- 
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cept of a multifactorial modulation by the hypothalamus 
(21,42). 
Our data obtained by pulsatile application of secreta- 
gogues show that OT given in combination with CRF or 
AVP significantly enhances ACTH secretion. In agree- 
ment with others (16,21) we observed synergism between 
OT and CRF on ACTH release. In contrast to previous 
studies (17, 22) which did not reveal an OT effect on 
AVP-induced ACTH release, our data clearly demon- 
strate that simultaneous exposure to OT and AVP pro- 
duces an additive effect on ACTH secretion. Thus, we 
conclude that the intracellular mechanism of action of 
AVP and OT appear to be similar, if not identical. This 
notion is supported by our observations of changes in 
cytosolic free calcium concentrations recorded with the 
calcium indicator Fura- in cultured, single, identified 
adenohypophyseal corticotrophs. These data further elu- 
cidate the mechanism of OT action on corticotroph 
ACTH release, because not only AVP but also OT evoked 
immediate increases in intracellular calcium levels in 
immunocytochemically identified corticotrophs. Since 
the corticotroph cells respond to OT even after removal 
of extracellular calcium, it seems reasonable to conclude 
that OT mobilizes calcium mainly from intracellular 
calcium stores. Previous studies using pituitary cell sus- 
pensions (46) or individual cells (24) also reported in- 
creased cytosolic free calcium and ACTH release in 
individual corticotrophs after challenges with AVP. Our 
data on the role of intracellular calcium stores are con- 
sistent with recent secretion studies carried out in cal- 
cium-free medium where ACTH release by OT was dem- 
onstrated, but it should be noted that depletion of intra- 
cellular calcium nearly abolished the OT response (25). 
The common mechanism which leads to the release of 
calcium from intracellular stores requires activation of 
phospholipase C and production of inositol 1,4,5-tris- 
phosphate (for review see Ref. 47). Our findings are 
consistent with this mechanism and indicate that OT is 
an effective ACTH-secretagogue utilizing this pathway 
to trigger secretion in rat corticotrophs. The intracellular 
stores, from which inositol 1,4,5-tris-phosphate effec- 
tively releases calcium into the cytosol in endocrine cells, 
are large (48, 49), and it is likely that these stores in 
corticotrophs constitute a calcium reservoir available for 
AVP and OT secretagogic actions. Subsequently, calcium 
discharged into the cytosol directly triggers exocytosis as 
observed in a-toxin permeabilized pituitary (50, 51) and 
other endocrine cells (52, 53). 
Taken together, we conclude that physiological con- 
centrations of OT evoke ACTH secretion from adeno- 
hypophyseal corticotrophs. Moreover, OT together with 
other ACTH secretagogues like AVP and CRF, can serve 
as important regulators of ACTH release during stress 
and under normal conditions. The mechanism of OT- 
induced ACTH release implies increases in intracellular 
calcium levels through calcium release from intracellular 
stores, which finally triggers exocytosis. 
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